1 / 8

Network Pharmacists Meeting May 2003

Network Pharmacists Meeting May 2003. Jo Keightley Chemotherapy Prescribing Development Pharmacist Sussex Cancer Network. Interaction with NCRN.  number & complexity of trials   workload & cost Duplication of work Sharing of dispensing procedures Sub-group to appraise trials

parvani-gautam
Download Presentation

Network Pharmacists Meeting May 2003

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Network Pharmacists MeetingMay 2003 Jo Keightley Chemotherapy Prescribing Development Pharmacist Sussex Cancer Network

  2. Interaction with NCRN •  number & complexity of trials   workload & cost • Duplication of work • Sharing of dispensing procedures • Sub-group to appraise trials • Capacity issues

  3. Workload and capacity • Increases in workload of up to 80% • Variation in methods used to quantify capacity • Develop national model • Consider impact of out-sourcing

  4. Clinical Guidelines • Rationalise range of treatments • Much variation in guidelines in different Networks • Variation in approach to non-NICE drugs in different Networks • Aim to reduce variation • National guidelines

  5. Chemotherapy benchmarking • Data generally difficult to collect • Impossible to determine how much spent on non-NICE approved indications • Financial planning difficult • Current IT systems inadequate

  6. Electronic Oncology Prescribing Systems • Several networks have EP • Many awaiting guidance on preferred provider • Essential features • Validated drug regime database • Treatment pathways • Audit trail • Compatibility with other systems

  7. Workforce development • No mention of pharmacy in WDC for Cancer! • Development of pharmacist’s role • Prescribing IV/SC chemotherapy • Prescribing oral chemotherapy eg Capecitabine clinics

  8. Future of the group • Find the missing pharmacists! • Aim to form a network of networks • Feed back to NDP

More Related